This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Krief, P. Articles by Maytal, J. Search for Related Content PubMed PubMed Citation Articles by Krief, P. Articles by Maytal, J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Epilepsy Social Bookmarking                         What's this?

Efficacy of Levetiracetam in Children With Epilepsy Younger Than 2 Years of Age

North Shore Long Island Jewish Medical Center, Schneider Children's Hospital, Albert Einstein College of Medicine, New Hyde Park, New York, pkrief{at}nshs.edu

Li Kan, MD

North Shore Long Island Jewish Medical Center, Schneider Children's Hospital, Albert Einstein College of Medicine, New Hyde Park, New York

Joseph Maytal, MD

North Shore Long Island Jewish Medical Center, Schneider Children's Hospital, Albert Einstein College of Medicine, New Hyde Park, New York

Despite the high incidence of epilepsy in very young children, the availability of approved antiepileptic drugs for this population is limited. This study assessed the efficacy and tolerability of levetiracetam in children younger than 2 years of age with various types of epilepsy. A single-center, retrospective chart review of 28 patients ranging in age from 2 weeks to 22 months treated with levetiracetam over a 2.5-year period was conducted. The mean dosage of levetiracetam was 39 mg/kg per day, and the mean duration of treatment was 6.3 months. The majority of patients (54%) were also taking 1 or 2 other antiepileptic drugs. A reduction in seizure frequency was found in 54%, with 14% achieving seizure freedom. Eight patients showed no response to levetiracetam treatment. Efficacy was highest among patients with generalized epilepsy. Adverse effects occurred in 2 patients and were behavioral in nature. Levetiracetam treatment was safe and effective in this group of very young patients with various types of epilepsy.

Key Words: levetiracetam • epilepsy

Journal of Child Neurology, Vol. 23, No. 5, 582-584 (2008)
DOI: 10.1177/0883073807309781


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?